news

Our latest
Press Releases & Updates

Latest press releases

RetinAI OCT Atlas® is now CE-marked for Clinical Use: one algorithm for AMD, DR, DME, and Glaucoma

RetinAI OCT Atlas® is now CE-marked under EU MDR 2017/745 for clinical use across AMD, Diabetic Retinopathy, DME, and Glaucoma, validated in the DILL study across 124 patients and three OCT devices.

RetinAI & OptymEdge Collaborate to Accelerate Ophthalmic Drug Development Through AI-Powered Reading Center Solutions

EarlySight announces strategic collaboration with RetinAI to enhance clinical Insights from its Cellularis® Retinal Imaging Platform

EarlySight and Ikerian (RetinAI) have announced a new collaboration to integrate EarlySight’s Cellularis® imaging technology with RetinAI’s AI-driven Discovery® platform. Together, the companies aim to enhance retinal imaging and analysis for clinical and research use.

EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions

EssilorLuxottica has acquired Ikerian AG, the parent company of RetinAI, strengthening its med-tech strategy with advanced AI and data-driven solutions that enhance clinical workflows and improve patient care in ophthalmology.

Latest updates

5th international Congress OCT Angiography [DECEMBER'17]

RetinAI will be presenting the latest company's developments in this year's edition of the 5th International Congress on OCT Angiography in Rome, on the 15-16th December. Don't forget to come to our session: Unleashing the potential of longitudinal image analysis in Optical Coherence Tomography.

NVIDIA GTC Munich 2017 [OCTOBER'17]

RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.

5th Medtech & Digital Health Forum Basel [OCTOBER'17]

RetinAI participated in the latest edition of the 5th Medtech & Digital Health Forum in Basel. The team had the opportunity to present our current developments and efforts towards bringing Artificial Intelligence to Ophthalmology, specially in developing countries.

Euretina 2017 + MICCAI 2017 [AUGUST'17]

RetinAI is getting ready for a September full of conferences and events! September 7-10th we will be in the 17th EURETINA Congress in Barcelona, followed by 4 days in MICCAI'2017 in Quebec. In Canada we will present our work on automatic segmentation of pathological retinal layers and participate in this year's edition of the RETOUCH challenge.

Contact us for more informations! We are happy to hear from you!